CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p
S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang Department of Respiratory Medicine, Huaihe Hospital of Henan University, Kaifeng, China.
The article “CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p, by S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (7): 3749-3760–DOI: 10.26355/eurrev_202004_20839–PMID: 32329852” has been withdrawn from the authors due to inaccuracies and mistakes.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadCircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang
CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 8
Pages: 3150-3150
DOI: 10.26355/eurrev_202104_25716